Evidence map›Paper›PMID 30781782›Full record

ArticleMaterials (Basel, Switzerland)2019

Formulation and Characterization of New Polymeric Systems Based on Chitosan and Xanthine Derivatives with Thiazolidin-4-One Scaffold.

Sandra Madalina Constantin, Frederic Buron, Sylvain Routier, Ioana Mirela Vasincu, Maria Apotrosoaei, Florentina Lupașcu, Luminița Confederat, Cristina Tuchilus, Marta Teodora Constantin, Alexandru Sava and 1 more

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Sandra Madalina ConstantinDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy "Grigore T. Popa", 16 University Street, 700115 Iasi, Romania. constantin.sandra@umfiasi.ro.ORCID 0000-0003-3190-8807
Frederic BuronInstitut de Chimie Organique et Analytique, Univ Orleans, CNRS, ICOA, UMR 7311, F-45067 Orléans, France. frederic.buron@univ-orleans.fr.ORCID 0000-0001-5773-1515
Sylvain RoutierInstitut de Chimie Organique et Analytique, Univ Orleans, CNRS, ICOA, UMR 7311, F-45067 Orléans, France. sylvain.routier@univ-orleans.fr.
Ioana Mirela VasincuDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy "Grigore T. Popa", 16 University Street, 700115 Iasi, Romania. ioanageangalau@yahoo.com.
Maria ApotrosoaeiDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy "Grigore T. Popa", 16 University Street, 700115 Iasi, Romania. apotrosoaei.maria@umfiasi.ro.
Florentina LupașcuDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy "Grigore T. Popa", 16 University Street, 700115 Iasi, Romania. florentina-geanina.l@umfiasi.ro.
Luminița ConfederatDepartment of Microbiology, Faculty of Pharmacy, University of Medicine and Pharmacy "Grigore T. Popa", 16 University Street, 700115 Iasi, Romania. luminita.confederat@umfiasi.ro.
Cristina TuchilusDepartment of Microbiology, Faculty of Pharmacy, University of Medicine and Pharmacy "Grigore T. Popa", 16 University Street, 700115 Iasi, Romania. cristina.tuchilus@umfiasi.ro.
Marta Teodora ConstantinUniversity of Kent, School of Physical Sciences, Canterbury CT2 7NH, UK. marta.constantin97@gmail.com.
Alexandru SavaDepartment of Analytical Chemistry; Faculty of Pharmacy, University of Medicine and Pharmacy "Grigore T. Popa", 16 University Street, 700115 Iasi, Romania. alexandru.i.sava@umfiasi.ro.
Lenuţa ProfireDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy "Grigore T. Popa", 16 University Street, 700115 Iasi, Romania. lenuta.profire@umfiasi.ro.
Grigore T. Popa University of Medicine and Pharmacy · ROCentre National de la Recherche Scientifique · FRUniversity of Kent · GB

Funding

CNCS-UEFISCDI 151 PED/2017
6 · The paper itself

Abstract

In the past many research studies have focused on the thiazolidine-4-one scaffold, due to the important biological effects associated with its heterocycle. This scaffold is present in the structure of many synthetic compounds, which showed significant biological effects such as antimicrobial, antifungal, antioxidant, anti-inflammatory, analgesic, antidiabetic effects. It was also identified in natural compounds, such as actithiazic acid, isolated from

Indexed as

antibacterial activitychitosanpolymeric systemsthiazolidine-4-one scaffold

Identifiers

PMID30781782
PMCPMC6416560
OpenAlexW2912600214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.